| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| Frmpd1 | Slc2a13 | ENSRNOP00000016839 | ENSRNOP00000021153 | FERM and PDZ domain-containing 1. | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | 0.491 |
| Frmpd1 | Spats2l | ENSRNOP00000016839 | ENSRNOP00000069610 | FERM and PDZ domain-containing 1. | SPATS2-like protein. | 0.501 |
| Frmpd1 | Tmem51 | ENSRNOP00000016839 | ENSRNOP00000019171 | FERM and PDZ domain-containing 1. | Similar to BC003277 protein (Predicted), isoform CRA_a. | 0.505 |
| Impa1 | Isyna1 | ENSRNOP00000014274 | ENSRNOP00000026821 | Inositol monophosphatase 1; Responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. Has broad substrate specificity and can use myo-inositol 1,3- diphosphate, myo-inositol 1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta- glycerophosphate, and 2'-AMP as substrates (By similarity). Is equally active with myo-inositol monophosphate and D-galactose 1-phosphate. | Inositol-3-phosphate synthase 1; Key enzyme in myo-inositol biosynthesis pathway that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1- phosphate in a NAD-dependent manner. Rate-limiting enzyme in the synthesis of all inositol-containing compounds (By similarity). | 0.977 |
| Impa1 | Slc2a13 | ENSRNOP00000014274 | ENSRNOP00000021153 | Inositol monophosphatase 1; Responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. Has broad substrate specificity and can use myo-inositol 1,3- diphosphate, myo-inositol 1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta- glycerophosphate, and 2'-AMP as substrates (By similarity). Is equally active with myo-inositol monophosphate and D-galactose 1-phosphate. | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | 0.501 |
| Isyna1 | Impa1 | ENSRNOP00000026821 | ENSRNOP00000014274 | Inositol-3-phosphate synthase 1; Key enzyme in myo-inositol biosynthesis pathway that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1- phosphate in a NAD-dependent manner. Rate-limiting enzyme in the synthesis of all inositol-containing compounds (By similarity). | Inositol monophosphatase 1; Responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. Has broad substrate specificity and can use myo-inositol 1,3- diphosphate, myo-inositol 1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta- glycerophosphate, and 2'-AMP as substrates (By similarity). Is equally active with myo-inositol monophosphate and D-galactose 1-phosphate. | 0.977 |
| Isyna1 | Slc2a13 | ENSRNOP00000026821 | ENSRNOP00000021153 | Inositol-3-phosphate synthase 1; Key enzyme in myo-inositol biosynthesis pathway that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1- phosphate in a NAD-dependent manner. Rate-limiting enzyme in the synthesis of all inositol-containing compounds (By similarity). | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | 0.523 |
| Slc22a12 | Slc2a13 | ENSRNOP00000028665 | ENSRNOP00000021153 | Solute carrier family 22 member 12; Required for efficient urate re-absorption in the kidney. Regulates blood urate levels. Mediates saturable urate uptake by facilitating the exchange of urate against organic anions or chloride ions (By similarity). | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | 0.504 |
| Slc2a13 | Frmpd1 | ENSRNOP00000021153 | ENSRNOP00000016839 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | FERM and PDZ domain-containing 1. | 0.491 |
| Slc2a13 | Impa1 | ENSRNOP00000021153 | ENSRNOP00000014274 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Inositol monophosphatase 1; Responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. Has broad substrate specificity and can use myo-inositol 1,3- diphosphate, myo-inositol 1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta- glycerophosphate, and 2'-AMP as substrates (By similarity). Is equally active with myo-inositol monophosphate and D-galactose 1-phosphate. | 0.501 |
| Slc2a13 | Isyna1 | ENSRNOP00000021153 | ENSRNOP00000026821 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Inositol-3-phosphate synthase 1; Key enzyme in myo-inositol biosynthesis pathway that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1- phosphate in a NAD-dependent manner. Rate-limiting enzyme in the synthesis of all inositol-containing compounds (By similarity). | 0.523 |
| Slc2a13 | Slc22a12 | ENSRNOP00000021153 | ENSRNOP00000028665 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Solute carrier family 22 member 12; Required for efficient urate re-absorption in the kidney. Regulates blood urate levels. Mediates saturable urate uptake by facilitating the exchange of urate against organic anions or chloride ions (By similarity). | 0.504 |
| Slc2a13 | Slc5a11 | ENSRNOP00000021153 | ENSRNOP00000073553 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Sodium/myo-inositol cotransporter 2; Involved in the sodium-dependent cotransport of myo-inositol (MI) with a Na(+):MI stoichiometry of 2:1. Exclusively responsible for apical MI transport and absorption in intestine. Also can transport D- chiro-inositol (DCI) but not L-fructose. Exhibits stereospecific cotransport of both D-glucose and D-xylose. May induce apoptosis through the TNF-alpha, PDCD1 pathway. May play a role in the regulation of MI concentration in serum, involving reabsorption in at least the proximal tubule of the kidney. | 0.554 |
| Slc2a13 | Spats2l | ENSRNOP00000021153 | ENSRNOP00000069610 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | SPATS2-like protein. | 0.498 |
| Slc2a13 | Swt1 | ENSRNOP00000021153 | ENSRNOP00000049813 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Similar to RIKEN cDNA 1200016B10 (Predicted), isoform CRA_a. | 0.531 |
| Slc2a13 | Tmem117 | ENSRNOP00000021153 | ENSRNOP00000008159 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Transmembrane protein 117. | 0.592 |
| Slc2a13 | Tmem51 | ENSRNOP00000021153 | ENSRNOP00000019171 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Similar to BC003277 protein (Predicted), isoform CRA_a. | 0.491 |
| Slc2a13 | Zcrb1 | ENSRNOP00000021153 | ENSRNOP00000006780 | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | Zinc finger CCHC-type and RNA-binding motif-containing protein 1. | 0.503 |
| Slc5a11 | Slc2a13 | ENSRNOP00000073553 | ENSRNOP00000021153 | Sodium/myo-inositol cotransporter 2; Involved in the sodium-dependent cotransport of myo-inositol (MI) with a Na(+):MI stoichiometry of 2:1. Exclusively responsible for apical MI transport and absorption in intestine. Also can transport D- chiro-inositol (DCI) but not L-fructose. Exhibits stereospecific cotransport of both D-glucose and D-xylose. May induce apoptosis through the TNF-alpha, PDCD1 pathway. May play a role in the regulation of MI concentration in serum, involving reabsorption in at least the proximal tubule of the kidney. | Proton myo-inositol cotransporter; H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | 0.554 |
| Spats2l | Frmpd1 | ENSRNOP00000069610 | ENSRNOP00000016839 | SPATS2-like protein. | FERM and PDZ domain-containing 1. | 0.501 |
